JAGX: Jaguar Health Inc Company Value to Net Income

Symbol and logo of brand Jaguar Animal Health (JAGX)

Jaguar Health, Inc. (JAGX) is developing a niche system of products derived from exotic flora, where loyalty among HIV patients is at its peak, although strict FDA regulations limit expansion. The asset's price trajectory on GURU.Markets, where the indicator stands at -0.10, is supported by the work of leading botanical pharmacologists. The project's economics rely on low costs during the mass production of capsules following the completion of expensive primary research.

JAGX Jaguar Health P/E Multiple (07/04/2022 - 11/17/2026)

Analytical breakdowns for Jaguar Health, Inc.

- price and consensus price forecast:
- market capitalization information:
Summary company analysis:JAGX, Jaguar Health
Finished products of Jaguar Health Inc

The business efficiency of Jaguar Health, Inc. (JAGX) is directly reflected in the dynamics of its earnings valuation. This ratio compares the total equity value to net income, determining the investment payback period. By analyzing the P/E ratio of Jaguar Health, Inc. (JAGX), an investor can identify whether the asset is overbought or undervalued. However, cash burn resulting from legal expenses and weak Mytesi sales distorts the calculation base. The critical risk of equity dilution renders current multiplier values extremely volatile.